Fed. Circ. Won't Revive Novartis Hemophilia Drug IP Suit
The Federal Circuit on Tuesday rejected a bid from Genetics Institute LLC to revive a suit against Novartis Vaccines & Diagnostics Inc. claiming that a GI patent for the formula for...To view the full article, register now.
Already a subscriber? Click here to view full article